BTC $78,442.13 -0.99%
ETH $2,483.42 -0.26%
BNB $749.92 +1.43%
XRP $1.42 +1.46%
SOL $103.16 -0.90%
TRX $0.3379 +0.97%
DOGE $0.0897 -1.29%
ADA $0.2205 -0.08%
BCH $256.68 -1.23%
LINK $12.53 -2.01%
HYPE $84.33 -1.20%
AAVE $128.93 -2.67%
SUI $0.8141 -1.87%
XLM $0.1880 -2.64%
ZEC $1,149.73 -0.68%
BTC $78,442.13 -0.99%
ETH $2,483.42 -0.26%
BNB $749.92 +1.43%
XRP $1.42 +1.46%
SOL $103.16 -0.90%
TRX $0.3379 +0.97%
DOGE $0.0897 -1.29%
ADA $0.2205 -0.08%
BCH $256.68 -1.23%
LINK $12.53 -2.01%
HYPE $84.33 -1.20%
AAVE $128.93 -2.67%
SUI $0.8141 -1.87%
XLM $0.1880 -2.64%
ZEC $1,149.73 -0.68%

The judge ruled that Bitfarms must immediately terminate its "poison pill" strategy aimed at opposing Riot Platforms' acquisition

2024-07-25 13:58:35

ChainCatcher news, the encrypted mining company Riot Platforms stated in a declaration on July 24 that the Ontario Capital Markets Tribunal issued a cease trading order on Bitfarms' poison pill plan, immediately terminating the strategy.

Since June 13, Bitfarms has been opposing Riot Platforms' $950 million acquisition offer, claiming that Riot unfairly undervalued the company. The company adopted a poison pill strategy known as a "rights plan" to attempt to block the acquisition.

Poison pill strategies are typically used by companies to prevent hostile takeovers. Under this strategy, existing shareholders purchase additional shares at a significant discount, diluting the value of the shares held by the acquirer. According to Bitfarms' now-defunct rights plan, if any entity acquires more than 15% of the company's outstanding shares before September 10, Bitfarms will issue new shares to other existing shareholders, thereby reducing that entity's ownership.

app_icon
ChainCatcher Building the Web3 world with innovations.